Effect of erythromycin on bronchial hyperreactivity and inflammation in ovalbumin-sensitized brown Norway rats

Respiratory Physiology and Neurobiology

Volumn 161, Issue 3, 2008, Pages 267-272

  Lin, Ching Chi ^a,b   Liaw, Shwu Fang ^a   Wu, Kun Ming ^a   Lin, Chih Hsueh ^a  

^a Department of Medical Research ^*  (Taiwan)

^b NURSING AND MANAGEMENT COLLEGE   (Taiwan)

Author keywords

Asthma; Bronchial hyperreactivity; Erythromycin; Ovalbumin

Indexed keywords

ACETYLCHOLINE; ERYTHROMYCIN; MESSENGER RNA; OVALBUMIN; SODIUM CHLORIDE;

AEROSOL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREATHING; BRONCHITIS; BRONCHUS HYPERREACTIVITY; BROWN NORWAY RAT; CONTROLLED STUDY; CYTOKINE PRODUCTION; HISTOPATHOLOGY; LUNG FUNCTION; LUNG FUNCTION TEST; LUNG LAVAGE; MALE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; RAT; T LYMPHOCYTE; TH2 CELL;

ANIMALS; BRONCHIAL HYPERREACTIVITY; BRONCHOALVEOLAR LAVAGE FLUID; CHLAMYDOPHILA; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROMYCIN; GENE EXPRESSION REGULATION; INFLAMMATION; MALE; MYCOPLASMA; OVALBUMIN; PLETHYSMOGRAPHY, WHOLE BODY; PROTEIN SYNTHESIS INHIBITORS; RATS; RATS, INBRED BN; T-LYMPHOCYTES;

EID: 43149102069     PISSN: 15699048     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.resp.2008.02.015     Document Type: Article

References (33)

1. Adachi T., Motojima S., Hirata A., Fukuda T., Kihara N., Kosaku A., Ohtake H., and Makino S. Eosinophil apoptosis caused by theophylline, glucocorticoids, and macrolides after stimulation with IL-5. J. Allergy Clin. Immunol. 98 (1996) S207-S215
2. Amayasu H., Yoshida S., Ebana S., Yamamoto Y., Nishikawa T., Shoji T., Nakagawa H., Hasegawa H., Nakabayashi M., and Ishizaki Y. Clarithromycin suppresses bronchial hyperresponsiveness associated with eosinophilic inflammation in patients with asthma. Ann. Allergy Asthma Immunol. 84 (2000) 594-598
3. Anderson R., Theron A.J., and Feldman C. Membrane-stabilizing, anti-inflammatory interactions of macrolides with human neutrophils. Inflammation 20 (1996) 693-705
4. Barnes P.J., and Adcock I.M. Transcription factors and asthma. Eur. Respir. J. 12 (1998) 221-234
5. Biscione G.L., Corne J., Chauhan A.J., and Johnston S.L. Increased frequency of detection of Chlamydophila pneumoniae in asthma. Eur. Respir. J. 24 (2004) 745-749
6. Black P.N., Scicchitano R., Jenkins C.R., Blasi F., Allegra L., Wlodarczyk J., and Cooper B.C. Serological evidence of infection with Chlamydia pneumoniae is related to the severity of asthma. Eur. Respir. J. 15 (2000) 254-259
7. Black P.N., Blasi F., Jenkins C.R., Scicchitano R., Mills G.D., Rubinfeld A.R., Ruffin R.E., Mullins P.R., Dangain J., Cooper B.C., David D.B., and Allegra L. Trial of roxithromycin in subjects with asthma and serological evidence of infection with Chlamydia pneumoniae. Am. J. Respir. Crit. Care Med. 164 (2001) 536-541
8. Daxboeck F., Krause R., and Wenisch C. Laboratory diagnosis of Mycoplasma pneumoniae infection. Clin. Microbiol. Infect. 9 (2003) 263-273
9. Dowell S.F., et al. Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clin. Infect. Dis. 33 (2001) 492-503
10. Graham V., Lasserson T.J., and Rowe B.H. Antibiotics for acute asthma. Cochrane Database Syst. Rev. 2 (2001) CD002741
11. Hahn D.L. Treatment of Chlamydia pneumoniae infection in adult asthma: a before-after trial. J. Fam. Pract. 41 (1995) 345-351
12. Hammerschlag M.R. Mycoplasma pneumoniae infections. Curr. Opin. Infect. Dis. 14 (2001) 181-186
13. Hartert T.V., and Peebles Jr. R.S. Epidemiology of asthma: the year in review. Curr. Opin. Pulm. Med. 6 (2000) 4-9
14. Homma H., Yamanaka A., Tanimoto S., Tamura M., Chijimatsu Y., Kira S., and Izumi T. Diffuse panbronchiolitis A disease of the transitional zone of the lung. Chest 83 (1983) 63-69
15. Huittinen T., Hahn D., Anttila T., Wahlström E., Saikku P., and Leinonen M. Host immune response to Chlamydia pneumoniae heat shock protein 60 is associated with asthma. Eur. Respir. J. 17 (2001) 1078-1082
16. Johnston S.L., and Martin R.J. Chlamydophila pneumoniae and Mycoplasma pneumoniae: a role in asthma pathogenesis?. Am. J. Respir. Crit. Care Med. 172 (2005) 1078-1089
17. Johnston S.L., Blasi F., Black P.N., Martin R.J., Farrell D.J., Nieman R.B., and TELICAST Investigators. The effect of telithromycin in acute exacerbations of asthma. N. Engl. J. Med. 354 (2006) 1589-1600
18. Konno S., Asano K., Kurokawa M., Ikeda K., Okamoto K., and Adachi M. Antiasthmatic activity of a macrolide antibiotic, roxithromycin: analysis of possible mechanisms in vitro and in vivo. Int. Arch. Allergy Immunol. 105 (1994) 308-316
19. Kraft M., Cassell G.H., Pak J., and Martin R.J. Mycoplasma pneumoniae and Chlamydia pneumoniae in asthma: effect of clarithromycin. Chest 121 (2002) 1782-1788
20. Lieberman D., Lieberman D., Printz S., Ben-Yaakov M., Lazarovich Z., Ohana B., Friedman M.G., Dvoskin B., Leinonen M., and Boldur I. Atypical pathogen infection in adults with acute exacerbation of bronchial asthma. Am. J. Respir. Crit. Care Med. 167 (2003) 406-410
21. Lin C.C., Lin C.Y., and Ma H.Y. Pulmonary function changes and increased Th-2 cytokine expression and nuclear factor kB activation in the lung after sensitization and allergen challenge in brown Norway rats. Immunol. Lett. 73 (2000) 57-64
22. Lin C.C., Lin C.Y., Liaw S.F., and Chen A. Pulmonary function changes and immunomodulation of Th 2 cytokine expression induced by aminophylline after sensitization and allergen challenge in brown Norway rats. Ann. Allergy Asthma Immunol. 88 (2002) 215-222
23. Lin C.C., Lin C.Y., Liaw S.F., and Chen A. Pulmonary function changes and immunomodulation of cytokine expression by zafirlukast after sensitization and allergen challenge in brown Norway rats. Clin. Exp. Allergy 32 (2002) 960-966
24. McDonough E.A., Barrozo C.P., Russell K.L., and Metzgar D. A multiplex PCR for detection of Mycoplasma pneumoniae, Chlamydophila pneumoniae, Legionella pneumophila, and Bordetella pertussis in clinical specimens. Mol. Cell. Probes 19 (2005) 314-322
25. Miyatake H., Taki F., Taniguchi H., Suzuki R., Takagi K., and Satake T. Erythromycin reduces the severity of bronchial hyperresponsiveness in asthma. Chest 99 (1991) 670-673
26. Pasternack R., Huhtala H., and Karjalainen J. Chlamydophila (Chlamydia) pneumoniae serology and asthma in adults: a longitudinal analysis. J. Allergy Clin. Immunol. 116 (2005) 1123-1128
27. Richeldi L., Ferrara G., Fabbri L.M., Lasserson T.J., and Gibson P.G. Macrolides for chronic asthma. Cochrane Database Syst. Rev. 4 (2005) CD002997
28. Shoji T., Yoshida S., Sakamoto H., Hasegawa H., Nakagawa H., and Amayasu H. Anti-inflammatory effect of roxithromycin in patients with aspirin-intolerant asthma. Clin. Exp. Allergy 29 (1999) 950-956
29. Strålin K., Bäckman A., Holmberg H., Fredlund H., and Olcén P. Design of a multiplex PCR for Streptococcus pneumoniae, Haemophilus influenzae Mycoplasma pneumoniae and Chlamydophila pneumoniae to be used on sputum samples. APMIS 113 (2005) 99-111
30. Takizawa H., Desaki M., Ohtoshi T., Kikutani T., Okazaki H., Sato M., Akiyama N., Shoji S., Hiramatsu K., and Ito K. Erythromycin suppresses interleukin 6 expression by human bronchial epithelial cells: a potential mechanism of its anti-inflammatory action. Biochem. Biophys. Res. Commun. 210 (1995) 781-786
31. Tamaoki J., Tagaya E., Sakai A., and Konno K. Effects of macrolide antibiotics on neurally mediated contraction of human isolated bronchus. J. Allergy Clin. Immunol. 95 (1995) 853-859
32. ten Brinke A., van Dissel J.T., Sterk P.J., Zwinderman A.H., Rabe K.F., and Bel E.H. Persistent airflow limitation in adult-onset nonatopic asthma is associated with serologic evidence of Chlamydia pneumoniae infection. J. Allergy Clin. Immunol. 107 (2001) 449-454
33. Wallwork B., and Coman W. Chronic rhinosinusitis and eosinophils: do macrolides have an effect?. Curr. Opin. Otolaryngol. Head Neck Surg. 12 (2004) 14-17